This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House
EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stock Under $10 that he thinks could potentially double or triple in the next 6 to 12-months. See what he's trading today with a 14-day FREE pass.

Medidata Solutions Inc. (MDSO): Today's Featured Technology Laggard

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Medidata Solutions ( MDSO) pushed the Technology sector lower today making it today's featured Technology laggard. The sector as a whole closed the day up 1.1%. By the end of trading, Medidata Solutions fell $11.98 (-22.7%) to $40.71 on heavy volume. Throughout the day, 10,506,970 shares of Medidata Solutions exchanged hands as compared to its average daily volume of 754,000 shares. The stock ranged in price between $37.15-$43.50 after having opened the day at $43.08 as compared to the previous trading day's close of $52.69. Other companies within the Technology sector that declined today were: Edgewater Technology ( EDGW), down 13.3%, Lexmark International ( LXK), down 11.2%, UBIC ( UBIC), down 10.1% and Castlight Health Inc Class B ( CSLT), down 7.3%.

Medidata Solutions, Inc. provides cloud-based clinical development solutions for life sciences in the United States and internationally. Medidata Solutions has a market cap of $2.9 billion and is part of the computer software & services industry. Shares are down 12.9% year to date as of the close of trading on Monday. Currently there are 6 analysts that rate Medidata Solutions a buy, no analysts rate it a sell, and 1 rates it a hold.

TheStreet Ratings rates Medidata Solutions as a hold. The company's strengths can be seen in multiple areas, such as its robust revenue growth, solid stock price performance and good cash flow from operations. However, as a counter to these strengths, we also find weaknesses including deteriorating net income, disappointing return on equity and generally higher debt management risk.

On the positive front, China BAK Battery ( CBAK), up 12.0%, SunEdison ( SUNE), up 11.9%, Crossroads Systems ( CRDS), up 11.8% and Varonis Systems ( VRNS), up 11.4% , were all gainers within the technology sector with Texas Instruments ( TXN) being today's featured technology sector leader.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the technology sector could consider Technology Select Sector SPDR ( XLK) while those bearish on the technology sector could consider ProShares Ultra Short Technology ( REW).

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Submit an article to us!
DOW 17,042.90 -28.32 -0.17%
S&P 500 1,972.29 -5.51 -0.28%
NASDAQ 4,493.39 -12.4620 -0.28%

Brokerage Partners

Top Rated Stocks Top Rated Funds Top Rated ETFs